Pacira Pharmaceuticals buy Royal Bank of Canada
Start price
01.03.23
/
50%
€40.00
Target price
01.03.24
€71.20
Performance (%)
-34.50%
End price
02.03.24
€26.20
Summary
This prediction ended on 02.03.24 with a price of €26.20. Massive losses of -34.50% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pacira Pharmaceuticals | 2.041% | 2.041% | -3.846% | -39.394% |
| iShares Core DAX® | 0,27 % | 2,50 % | 3,33 % | 50,44 % |
| iShares Nasdaq 100 | 1,88 % | 3,49 % | 35,66 % | 88,23 % |
| iShares Nikkei 225® | 3,58 % | 8,13 % | 56,65 % | 65,17 % |
| iShares S&P 500 | 0,15 % | 1,92 % | 24,11 % | 64,49 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Royal Bank of Canada from $80.00 to $76.00. They now have an "outperform" rating on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Royal_Bank_of_Canada for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€19.10
31.07.24
31.07.24
€34.16
31.07.25
31.07.25
-5.24%
01.08.25
01.08.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
01.03.24
01.03.24
€41.56
01.03.25
01.03.25
-16.03%
02.03.25
02.03.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
03.11.23
03.11.23
€54.04
03.11.24
03.11.24
-46.48%
04.11.24
04.11.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€27.40
03.10.23
03.10.23
€65.04
03.10.24
03.10.24
-45.99%
04.10.24
04.10.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€34.80
03.08.23
03.08.23
€62.07
03.08.24
03.08.24
-47.13%
04.08.24
04.08.24

